As discussed above, the well-known tumor suppressive activity of the TGFβ signaling pathway can be either lost in the presence of an active PI3K pathway or converted to a tumor promoting pathway, which may confer therapy resistance [45,67,74,75]. This evidence concerns the gene PIK3CB and neoplasm.